Improve Research Reproducibility A Bio-protocol resource
Concise Method
tooltip

Intracerebroventricular and Subcutaneous Injections

KT Katherine G. Tennant
SL Sarah R. Lindsley
MK Melissa A. Kirigiti
CT Cadence True
PK Paul Kievit
ask Ask a question
Favorite

For intracerebroventricular injections, FGF1 (3 µg, dissolved in sterile saline) or vehicle (saline) was injected over 10 s in a final volume of 4 µL using an injector with a 1-mm projection. For subcutaneous injections every other day, FGF1 was administered at a dose of 0.5 mg/kg body weight. All injections were done in the morning.

Copyright and License information:  ©2019 by the American Diabetes Association.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A